Age-related Changes in Bone Biochemical Markers and Their Relationship with Bone Mineral Density in Normal Chinese Women

Overview

Journal J Bone Miner Metab

Specialty Endocrinology

Date 2006 Aug 29

PMID 16937270

Citations 14

Authors

Yin-Zhen Pi

Xian-Ping Wu

Shi-Ping Liu

Xiang-Hang Luo

Xing-Zhi Cao

Hui Xie

Er-Yuan Liao

Affiliations

Soon will be listed here.

Abstract

Measurements of bone biochemical markers are increasingly being used to evaluate the state of bone turnover in the management of bone metabolic diseases, especially osteoporosis. However, changes in the bone turnover rate vary with age. The aim of this study was to establish the laboratory reference range of serum bone-specific alkaline phosphatase (sBAP), serum type I collagen cross-linked C-terminal telopeptide (sCTx), and urine CTx (uCTx), based on values from 665 healthy Chinese women aged 20-80 years. We measured the levels of sBAP, sCTx, serum alkaline phosphatase (sALP), and uCTx and evaluated the age-related changes and their relationship with bone mineral density (BMD) in the anteroposterior (AP) lumbar spine, hip, and left forearm. We found significant correlations between biochemical markers and age, with coefficients of determination (R (2)) of 0.358 for sBAP, 0.126 for sCTx, 0.125 for uCTx, and 0.336 for sALP. The net changes in different biochemical markers were inversely correlated with the rates of BMD loss in the AP lumbar spine. After correction for age, body weight, and height, the levels of the markers had significant negative correlations with the BMD of the AP lumbar spine, femoral neck, and ultradistal forearm. All four biochemical markers had the highest negative correlation with BMD of the AP lumbar spine (partial correlation coefficients of -0.366, -0.296, -0.290, and -0.258 for sBAP, sCTx, uCTx, and sALP, respectively). The mean and SD values of these markers in premenopausal and postmenopausal women with normal BMD values were used as the normal reference ranges. The reference ranges of sBAP, sCTx, and uCTx for pre- vs postmenopausal women were 17.3 +/- 6.23 vs 18.9 +/- 7.52 U/l, 3.18 +/- 1.49 vs 3.23 +/- 1.57 nmol/l, and 15.5 +/- 11.4 vs 16.2 +/- 12.4 nM bone collagen equivalents/mM urinary creatinine, respectively. Levels of the bone formation marker (sBAP) and bone resorption markers (sCTx, uCTx) increased rapidly in women with osteopenia or osteoporosis, indicating that they may be sensitive markers to determine the bone turnover rate in healthy Chinese women.

Citing Articles

Osteopenia Metabolomic Biomarkers for Early Warning of Osteoporosis.

Wang J, Yan D, Wang S, Zhao A, Hou X, Zheng X Metabolites. 2025; 15(1).

PMID: 39852408 PMC: 11767427. DOI: 10.3390/metabo15010066.

Peripheral extracellular vesicles in neurodegeneration: pathogenic influencers and therapeutic vehicles.

Liu X, Shen L, Wan M, Xie H, Wang Z J Nanobiotechnology. 2024; 22(1):170.

PMID: 38610012 PMC: 11015679. DOI: 10.1186/s12951-024-02428-1.

The Use of Bone-Turnover Markers in Asia-Pacific Populations.

Vasikaran S, Thambiah S, Tan R, Loh T Ann Lab Med. 2023; 44(2):126-134.

PMID: 37869778 PMC: 10628755. DOI: 10.3343/alm.2023.0214.

Bone metabolism in Chinese patients after laparoscopic Roux-en-Y gastric bypass.

Wang C, Zhang H, Xu T, Zou J, Chen J, Zhang P Transl Cancer Res. 2022; 9(4):2534-2541.

PMID: 35117613 PMC: 8799154. DOI: 10.21037/tcr.2020.03.01.

Reference Intervals for Bone Turnover Markers in Korean Healthy Women.

Cho D, Chung J, Chung M, Cho J, Chung D J Bone Metab. 2020; 27(1):43-52.

PMID: 32190608 PMC: 7064366. DOI: 10.11005/jbm.2020.27.1.43.

References

Chaki O, Yoshikata I, Kikuchi R, Nakayama M, Uchiyama Y, Hirahara F . The predictive value of biochemical markers of bone turnover for bone mineral density in postmenopausal Japanese women. J Bone Miner Res. 2000; 15(8):1537-44. DOI: 10.1359/jbmr.2000.15.8.1537. View

Garnero P, Shih W, Gineyts E, Karpf D, Delmas P . Comparison of new biochemical markers of bone turnover in late postmenopausal osteoporotic women in response to alendronate treatment. J Clin Endocrinol Metab. 1994; 79(6):1693-700. DOI: 10.1210/jcem.79.6.7989477. View

Sone T, Miyake M, Takeda N, Fukunaga M . Urinary excretion of type I collagen crosslinked N-telopeptides in healthy Japanese adults: age- and sex-related changes and reference limits. Bone. 1995; 17(4):335-9. DOI: 10.1016/s8756-3282(95)00243-x. View

Eastell R, Colwell A, Hampton L, Reeve J . Biochemical markers of bone resorption compared with estimates of bone resorption from radiotracer kinetic studies in osteoporosis. J Bone Miner Res. 1997; 12(1):59-65. DOI: 10.1359/jbmr.1997.12.1.59. View

Wu X, Liao E, Zhang H, Shan P, Cao X, Liu S . Establishment of BMD reference plots and determination of peak BMD at multiple skeletal regions in mainland Chinese women and the diagnosis of osteoporosis. Osteoporos Int. 2003; 15(1):71-9. DOI: 10.1007/s00198-003-1517-x. View

Ross P, Knowlton W . Rapid bone loss is associated with increased levels of biochemical markers. J Bone Miner Res. 1998; 13(2):297-302. DOI: 10.1359/jbmr.1998.13.2.297. View

Rogers A, Hannon R, Eastell R . Biochemical markers as predictors of rates of bone loss after menopause. J Bone Miner Res. 2000; 15(7):1398-404. DOI: 10.1359/jbmr.2000.15.7.1398. View

Nielsen H, Brixen K, Bouillon R, Mosekilde L . Changes in biochemical markers of osteoblastic activity during the menstrual cycle. J Clin Endocrinol Metab. 1990; 70(5):1431-7. DOI: 10.1210/jcem-70-5-1431. View

Chesnut 3rd C, Bell N, Clark G, Drinkwater B, English S, JOHNSON Jr C . Hormone replacement therapy in postmenopausal women: urinary N-telopeptide of type I collagen monitors therapeutic effect and predicts response of bone mineral density. Am J Med. 1997; 102(1):29-37. DOI: 10.1016/s0002-9343(96)00387-7. View

10.

van Daele P, Seibel M, Burger H, Hofman A, Grobbee D, van Leeuwen J . Case-control analysis of bone resorption markers, disability, and hip fracture risk: the Rotterdam study. BMJ. 1996; 312(7029):482-3. PMC: 2349981. DOI: 10.1136/bmj.312.7029.482. View

11.

Garnero P, Sornay-Rendu E, Claustrat B, Delmas P . Biochemical markers of bone turnover, endogenous hormones and the risk of fractures in postmenopausal women: the OFELY study. J Bone Miner Res. 2000; 15(8):1526-36. DOI: 10.1359/jbmr.2000.15.8.1526. View

12.

Delmas P . Biochemical markers of bone turnover. J Bone Miner Res. 1993; 8 Suppl 2:S549-55. DOI: 10.1002/jbmr.5650081323. View

13.

Ravn P, Fledelius C, Rosenquist C, Overgaard K, Christiansen C . High bone turnover is associated with low bone mass in both pre- and postmenopausal women. Bone. 1996; 19(3):291-8. DOI: 10.1016/8756-3282(96)00201-3. View

14.

Garnero P, Sornay-Rendu E, Duboeuf F, Delmas P . Markers of bone turnover predict postmenopausal forearm bone loss over 4 years: the OFELY study. J Bone Miner Res. 1999; 14(9):1614-21. DOI: 10.1359/jbmr.1999.14.9.1614. View

15.

Chailurkit L, Ongphiphadhanakul B, Piaseu N, Saetung S, Rajatanavin R . Biochemical markers of bone turnover and response of bone mineral density to intervention in early postmenopausal women: an experience in a clinical laboratory. Clin Chem. 2001; 47(6):1083-8. View

16.

Takahashi M, Kushida K, Hoshino H, Ohishi T, Inoue T . Biochemical markers of bone turnover do not decline after menopause in healthy women. Br J Obstet Gynaecol. 1999; 106(5):427-31. DOI: 10.1111/j.1471-0528.1999.tb08295.x. View

17.

Rosen C, Chesnut 3rd C, Mallinak N . The predictive value of biochemical markers of bone turnover for bone mineral density in early postmenopausal women treated with hormone replacement or calcium supplementation. J Clin Endocrinol Metab. 1997; 82(6):1904-10. DOI: 10.1210/jcem.82.6.4004. View

18.

Gorai I, Chaki O, Nakayama M, MINAGUCHI H . Urinary biochemical markers for bone resorption during the menstrual cycle. Calcif Tissue Int. 1995; 57(2):100-4. DOI: 10.1007/BF00298428. View

19.

Hannon R, Eastell R . Preanalytical variability of biochemical markers of bone turnover. Osteoporos Int. 2001; 11 Suppl 6:S30-44. DOI: 10.1007/s001980070004. View

20.

Liao E, Wu X, Deng X, Huang G, Zhu X, Wang W . Age-related bone mineral density, accumulated bone loss rate and prevalence of osteoporosis at multiple skeletal sites in chinese women. Osteoporos Int. 2002; 13(8):669-76. DOI: 10.1007/s001980200091. View